Posted 3 months ago

A Phase 2 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Patients With Stage 4 Non-Small Cell Lung Cancer

ClinicalTrials.gov ID  NCT06246110

Protocol number EIK1001-005

Sponsor Eikon Therapeutics